Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-142070

Chief Legal Officer acquired 55,668 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Ali-Jackson Kamil · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2016-09-15 Other acquisition : show line 1 in the form +50,878 71,167 D
2016-09-15 Other acquisition : show line 2 in the form +4,790 75,957 D
Loading xslF345X03/doc4.xml…